XRTX - XORTX Therapeutics Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.88 -0.03 (-3.27%)	---	---	---	0.0 (0.08%)	-0.01 (-1.16%)	0.0 (-0.48%)	0.0 (-0.41%)

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Category: /stock/categories/na

Market Period: AfterHours

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:: 0.0
VWAP:: 0.85
RVol:: 0.3341

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.85 -0.01 (-1.14%)	Oct 16 15:48
1m	Price decrease 1m	0.85 -0.01 (-1.16%)	Oct 16 10:49
1m	Price decrease 1m	0.83 -0.03 (-3.04%)	Oct 15 17:23
60m	Price decrease 60m	0.83 -0.04 (-5.05%)	Oct 15 17:23
10m	Price decrease 10m	0.83 -0.03 (-3.04%)	Oct 15 17:23